GlaxoSmithKline Pharmaceuticals Limited
Stock Forecast, Prediction & Price Target
GlaxoSmithKline Pharmaceuticals Limited Financial Estimates
GlaxoSmithKline Pharmaceuticals Limited Revenue Estimates
GlaxoSmithKline Pharmaceuticals Limited EBITDA Estimates
GlaxoSmithKline Pharmaceuticals Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| ₹31.98B N/A | ₹32.78B 2.47% | ₹34.53B 5.35% | Avg: ₹41.69B Low: ₹40.66B High: ₹42.15B avg. 20.71% | |||
Net Income
% change YoY
| ₹3.58B N/A | ₹3.80B 6.31% | ₹5.89B 54.93% | Avg: ₹9.48B Low: ₹8.77B High: ₹10.60B avg. 60.73% | |||
EBITDA
% change YoY
| ₹5.35B N/A | ₹8.37B 56.32% | ₹8.87B 5.96% | Avg: ₹10.47B Low: ₹10.21B High: ₹10.58B avg. 18.00% | |||
EPS
% change YoY
| $21.14 N/A | $22.48 6.33% | $34.83 54.93% | Avg: $55.98 Low: $51.79 High: $62.6 avg. 60.70% | |||
Operating Expenses
% change YoY
| ₹11.53B N/A | ₹11.29B -2.05% | ₹7.38B -34.63% | Avg: ₹3.06B Low: ₹2.99B High: ₹3.10B avg. -58.45% | |||
FAQ
What is GlaxoSmithKline Pharmaceuticals Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 60.73% in 2026-2026.
We have gathered data from 4 analysts. Their low estimate is 8.77B, average is 9.48B and high is 10.60B.
What is GlaxoSmithKline Pharmaceuticals Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 20.71% in 2026-2026.
We have gathered data from 4 analysts. Their low revenue estimate is ₹40.66B, average is ₹41.69B and high is ₹42.15B.
What is GlaxoSmithKline Pharmaceuticals Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 60.70% in 2026-2026.
We have gathered data from 4 analysts. Their low earnings per share estimate is $51.79, average is $55.98 and high is ₹62.60.